<DOC>
	<DOCNO>NCT00270946</DOCNO>
	<brief_summary>This study design evaluate clinical benefit safety OrCel treatment venous ulcer . OrCel standard care compare standard care alone . Standard care consist currently accept compression therapy . Patients treat 12 week . Patients heal ulcer follow additional 12 week assess durability heal wound .</brief_summary>
	<brief_title>Evaluation Bilayered Cellular Matrix ( OrCel ) Treatment Venous Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<mesh_term>Postphlebitic Syndrome</mesh_term>
	<mesh_term>Postthrombotic Syndrome</mesh_term>
	<criteria>Any race , 18 85 year age Male female Chronic venous insufficiency Ulcer size 2 20 sq cm , inclusive Ulcer present least one month ABI &gt; 0.7 Decrease wound size &gt; 35 % Screening Phase Infection ulcer site Uncontrolled diabetes mellitus Previous treatment exclude medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>Venous leg ulcer</keyword>
	<keyword>OrCel</keyword>
	<keyword>Compression therapy</keyword>
</DOC>